Uninsured Americans pay high costs for an insulin Eli Lilly vowed to price at $25, Sen. Warren says

Uninsured Americans pay nearly $98 on average for a vial of Eli Lilly’s generic insulin, even after the company pledged to cut the product’s list price to $25 per vial, according to a report released Thursday by Sen. Elizabeth Warren.

Eli Lilly earlier this year vowed to slash the list price of its generic insulin, Lispro, from $82.42 per vial starting on May 1. The Indianapolis-based pharmaceutical company is one of the world’s largest insulin manufacturers.

The Massachusetts senator’s report surveyed more than 300 chain and independent pharmacies in the U.S. between June 9 and 28 to determine whether Eli Lilly’s announced price cut “translated into real relief for patients.”

The survey found that a third of pharmacies charged uninsured patients $164 or more for a vial of Eli Lilly’s Lispro.